Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 2 | 79.5% |
| Food and Beverage | $645.80 | 21 | 20.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $2,500 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $223.96 | 10 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $165.28 | 1 | $0 (2018) |
| Dompe US, Inc. | $98.68 | 2 | $0 (2023) |
| BIOTISSUE HOLDINGS INC. | $33.40 | 1 | $0 (2024) |
| Volpara Health, Inc | $24.88 | 1 | $0 (2022) |
| Harrow Eye, LLC | $22.30 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $22.22 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $18.14 | 1 | $0 (2018) |
| Eyevance Pharmaceuticals LLC | $13.01 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $949.12 | 9 | Merck Sharp & Dohme LLC ($750.00) |
| 2023 | $1,872 | 6 | Merck Sharp & Dohme LLC ($1,750) |
| 2022 | $104.70 | 3 | Dompe US, Inc. ($66.18) |
| 2021 | $25.36 | 2 | Eyevance Pharmaceuticals LLC ($13.01) |
| 2019 | $11.58 | 1 | AstraZeneca Pharmaceuticals LP ($11.58) |
| 2018 | $183.42 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($165.28) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: Ophthalmology | ||||||
| 10/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Ophthalmology | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Ophthalmology | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 08/27/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: OPTOMETRY | ||||||
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $33.40 | General |
| 07/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Ophthalmology | ||||||
| 05/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Ophthalmology | ||||||
| 12/07/2023 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/16/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Ophthalmology | ||||||
| 09/01/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Ophthalmology | ||||||
| 08/07/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Ophthalmology | ||||||
| 07/17/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 02/09/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Ophthalmology | ||||||
| 11/08/2022 | Volpara Health, Inc | — | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| 06/30/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Ophthalmology | ||||||
| 05/24/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $66.18 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/16/2021 | Eyevance Pharmaceuticals LLC | Tobradex ST (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Anti-Infective/Steroid | ||||||
| 11/03/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $12.35 | General |
| 04/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $165.28 | General |
| 01/09/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 668 | 669 | $72,064 | $19,228 |
| 2022 | 8 | 543 | 548 | $51,170 | $13,828 |
| 2021 | 16 | 1,493 | 1,572 | $174,383 | $48,701 |
| 2020 | 18 | 1,606 | 1,898 | $111,683 | $35,616 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 204 | 204 | $21,770 | $7,132 | 32.8% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 176 | 176 | $14,970 | $4,880 | 32.6% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 66 | 67 | $7,012 | $1,562 | 22.3% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 63 | 63 | $12,097 | $1,336 | 11.0% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 44 | 44 | $4,972 | $1,200 | 24.1% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 25 | 25 | $3,484 | $875.04 | 25.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 13 | 13 | $3,195 | $835.25 | 26.1% |
| 77067 | Screening mammography | Office | 2023 | 16 | 16 | $1,975 | $647.73 | 32.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 15 | 15 | $1,338 | $441.55 | 33.0% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 35 | 35 | $910.00 | $229.83 | 25.3% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 11 | 11 | $341.00 | $88.77 | 26.0% |
| 77067 | Screening mammography | Facility | 2022 | 137 | 137 | $14,096 | $4,882 | 34.6% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 128 | 128 | $10,229 | $3,644 | 35.6% |
| 77067 | Screening mammography | Office | 2022 | 36 | 36 | $3,852 | $1,296 | 33.6% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 36 | 36 | $2,988 | $1,040 | 34.8% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 52 | 52 | $6,430 | $731.16 | 11.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 47 | 47 | $4,739 | $663.00 | 14.0% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 26 | 26 | $3,458 | $630.57 | 18.2% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 30 | 32 | $3,901 | $619.94 | 15.9% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 35 | 38 | $981.00 | $230.68 | 23.5% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 16 | 16 | $496.00 | $91.60 | 18.5% |
| 77067 | Screening mammography of both breasts | Facility | 2021 | 291 | 291 | $30,827 | $10,629 | 34.5% |
| 77063 | Screening digital tomography of both breasts | Facility | 2021 | 281 | 281 | $23,155 | $8,138 | 35.1% |
| 76642 | Ultrasound of one breast, limited | Facility | 2021 | 191 | 218 | $26,370 | $5,395 | 20.5% |
| 77065 | Diagnostic mammography of one breast | Facility | 2021 | 143 | 171 | $20,759 | $4,801 | 23.1% |
About Dr. Zeba Syed, MD
Dr. Zeba Syed, MD is a Diagnostic Radiology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801874730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zeba Syed, MD has received a total of $3,146 in payments from pharmaceutical and medical device companies, with $949.12 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Syed has provided services to 4,310 Medicare beneficiaries, totaling 4,687 services with total Medicare billing of $117,373. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Pittsburgh, PA
- Active Since 12/30/2005
- Last Updated 10/08/2020
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1801874730
Products in Payments
- Cequa (Drug) $223.96
- OXERVATE (Drug) $98.68
- VEVYE (Drug) $22.30
- REXULTI (Drug) $22.22
- INJECTAFER (Drug) $18.14
- Tobradex ST (Drug) $13.01
- FARXIGA (Drug) $11.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Pittsburgh
Robert Short, Md, MD
Diagnostic Radiology — Payments: $602,874
Abdullah Shaikh, Md, MD
Diagnostic Radiology — Payments: $282,737
Terri Gizienski
Diagnostic Radiology — Payments: $176,540
Dr. Andrew Klobuka, M.d, M.D
Diagnostic Radiology — Payments: $49,229
Alessandro Furlan
Diagnostic Radiology — Payments: $40,001
Margarita Zuley
Diagnostic Radiology — Payments: $20,113